SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 28.01 |
| Enterprise Value ($M) | 109.60 |
| Book Value ($M) | -183.63 |
| Book Value / Share | -1.82 |
| Price / Book | -0.15 |
| NCAV ($M) | -201.65 |
| NCAV / Share | -2.00 |
| Price / NCAV | -0.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.13 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.45 |
| Current Ratio | 1.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 196.51 |
| Assets | 214.53 |
| Liabilities | 398.16 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 29.62 |
| Operating Income | -130.96 |
| Net Income | -47.58 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -138.00 |
| Cash from Investing | 125.99 |
| Cash from Financing | -0.26 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 6.75 | 0.00 | |
| 13G/A | Primecap Management Co/ca/ | 4.58 | -53.43 | |
| 13G/A | Vanguard Group Inc | 5.85 | 0.00 | |
| 13G/A | BlackRock, Inc. | 2.40 | -66.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 206,660 | 532,101 | 38.84 | |
| 117,523 | 439,228 | 26.76 | |
| 94,246 | 316,607 | 29.77 | |
| 189,898 | 740,182 | 25.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EWTX – Edgewise Therapeutics, Inc. | EXEL – Exelixis, Inc. |
| FDMT – 4D Molecular Therapeutics, Inc. | GBIO – Generation Bio Co. |
| GERN – Geron Corporation |
Financial data and stock pages provided by
Fintel.io